The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A randomized phase 2 study of trametinib with or without GSK2141795 in patients with advanced uveal melanoma.
 
Alexander Noor Shoushtari
Consulting or Advisory Role - Castle Biosciences; Vaccinex
Research Funding - Bristol-Myers Squibb
Travel, Accommodations, Expenses - Bristol-Myers Squibb
 
Ragini Reiney Kudchadkar
No Relationships to Disclose
 
Katherine Panageas
Travel, Accommodations, Expenses - AstraZeneca
 
Rashmi Krishna Murthy
No Relationships to Disclose
 
Maria Jung
No Relationships to Disclose
 
Roshani Shah
No Relationships to Disclose
 
Bridget O'Donnell
No Relationships to Disclose
 
Talal T. Khawaja
No Relationships to Disclose
 
Yelena Shames
Honoraria - Novartis
Consulting or Advisory Role - Novartis
Travel, Accommodations, Expenses - Novartis
 
Nana A. Prempeh-Keteku
Consulting or Advisory Role - Bristol-Myers Squibb
Travel, Accommodations, Expenses - Bristol-Myers Squibb
 
Grazia Ambrosini
No Relationships to Disclose
 
Helen X. Chen
No Relationships to Disclose
 
Paul B. Chapman
Honoraria - Bristol-Myers Squibb; Daiichi Sankyo; Genentech/Roche; GlaxoSmithKline; Momenta Pharmaceuticals; Provectus
Consulting or Advisory Role - Bristol-Myers Squibb; Daiichi Sankyo; Genentech/Roche; GlaxoSmithKline; Momenta Pharmaceuticals; Provectus
Research Funding - Bristol-Myers Squibb; Genentech/Roche; GlaxoSmithKline
Travel, Accommodations, Expenses - Bristol-Myers Squibb
 
Gary K. Schwartz
Honoraria - AstraZeneca; Boehringer Ingelheim; Daiichi Sankyo; Novartis
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Daiichi Sankyo; Novartis
Patents, Royalties, Other Intellectual Property - Patent pending regarding development of PNAs for targeted cancer therapy (new technology)
Travel, Accommodations, Expenses - AstraZeneca; Boehringer Ingelheim; Daiichi Sankyo; Novartis
 
Richard D. Carvajal
Consulting or Advisory Role - AstraZeneca; Genentech; Iconic Therapeutics; Janssen; Merck; Novartis
Research Funding - Amgen; Bayer; Calithera Biosciences; Celldex; Daiichi Sankyo; Genentech; Incyte; Merck; Mirati Therapeutics; Novartis; Regeneron
 
Sapna Pradyuman Patel
Stock and Other Ownership Interests - Provectus
Honoraria - Dava Oncology; PCME, Rockpointe; PlatformQ Health
Consulting or Advisory Role - Amgen; Genentech/Roche
Speakers' Bureau - Bristol-Myers Squibb (Mexico); Merck
Research Funding - Bristol-Myers Squibb (Inst); Celgene (Inst); Celldex (Inst); Deciphera (Inst); GlaxoSmithKline (Inst); Novartis (Inst); Prometheus (Inst); Reata Pharmaceuticals (Inst)